In this study, we showed that TBL1XR1 is upregulated in NPC cell lines and clinical samples, and TBL1XR1 expression levels were correlated with the clinicopathologic characteristics of NPC patients. The gene discussed is TBL1XR1; the disease is nasopharyngeal carcinoma.